Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cannabidiol and anorexia:

Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome. Reuter SE et al. Clin Pharmacokinet. (2016)

Cannabinoids in Pain Management and Palliative Medicine. Häuser W et al. Dtsch Arztebl Int. (2017)

Medical marijuana for cancer. Kramer JL et al. CA Cancer J Clin. (2015)

Search results

Items: 1 to 20 of 22

1.

Cannaboinoid Antiemetic Therapy.

Taylor BN, Sauls RS.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Dec 21.

2.

Medical Use of Cannabinoids.

Fraguas-Sánchez AI, Torres-Suárez AI.

Drugs. 2018 Nov;78(16):1665-1703. doi: 10.1007/s40265-018-0996-1. Review.

PMID:
30374797
3.

Cannabinoid Delivery Systems for Pain and Inflammation Treatment.

Bruni N, Della Pepa C, Oliaro-Bosso S, Pessione E, Gastaldi D, Dosio F.

Molecules. 2018 Sep 27;23(10). pii: E2478. doi: 10.3390/molecules23102478. Review.

4.

A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome.

McCoy B, Wang L, Zak M, Al-Mehmadi S, Kabir N, Alhadid K, McDonald K, Zhang G, Sharma R, Whitney R, Sinopoli K, Snead OC 3rd.

Ann Clin Transl Neurol. 2018 Aug 1;5(9):1077-1088. doi: 10.1002/acn3.621. eCollection 2018 Sep.

5.

Cannabinoids in Pain Management and Palliative Medicine.

Häuser W, Fitzcharles MA, Radbruch L, Petzke F.

Dtsch Arztebl Int. 2017 Sep 22;114(38):627-634. doi: 10.3238/arztebl.2017.0627. Review.

6.

Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian cohort of 614 patients.

Fanelli G, De Carolis G, Leonardi C, Longobardi A, Sarli E, Allegri M, Schatman ME.

J Pain Res. 2017 May 22;10:1217-1224. doi: 10.2147/JPR.S132814. eCollection 2017.

7.

A user's guide to cannabinoid therapies in oncology.

Maida V, Daeninck PJ.

Curr Oncol. 2016 Dec;23(6):398-406. doi: 10.3747/co.23.3487. Epub 2016 Dec 21. Review.

8.

Cannabidiol: a potential treatment for post Ebola syndrome?

Reznik SE, Gardner EL, Ashby CR Jr.

Int J Infect Dis. 2016 Nov;52:74-76. doi: 10.1016/j.ijid.2016.09.020. Epub 2016 Sep 26.

9.

Cannabinoids for Symptom Management and Cancer Therapy: The Evidence.

Davis MP.

J Natl Compr Canc Netw. 2016 Jul;14(7):915-22. Review.

PMID:
27407130
10.
11.

Endocannabinoid System: A Multi-Facet Therapeutic Target.

Kaur R, Ambwani SR, Singh S.

Curr Clin Pharmacol. 2016;11(2):110-7. Review.

PMID:
27086601
12.

Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome.

Reuter SE, Martin JH.

Clin Pharmacokinet. 2016 Jul;55(7):807-812. doi: 10.1007/s40262-015-0363-2. Review.

PMID:
26883879
13.

Medical use of cannabis products: Lessons to be learned from Israel and Canada.

Ablin J, Ste-Marie PA, Schäfer M, Häuser W, Fitzcharles MA.

Schmerz. 2016 Feb;30(1):3-13. doi: 10.1007/s00482-015-0083-4.

PMID:
26767992
14.

Medical marijuana for cancer.

Kramer JL.

CA Cancer J Clin. 2015 Mar;65(2):109-22. doi: 10.3322/caac.21260. Epub 2014 Dec 10. Review.

15.

Cannabis for inflammatory bowel disease.

Naftali T, Mechulam R, Lev LB, Konikoff FM.

Dig Dis. 2014;32(4):468-74. doi: 10.1159/000358155. Epub 2014 Jun 23. Review.

PMID:
24969296
16.

Efficacy and safety of medical cannabinoids in older subjects: a systematic review.

van den Elsen GA, Ahmed AI, Lammers M, Kramers C, Verkes RJ, van der Marck MA, Rikkert MG.

Ageing Res Rev. 2014 Mar;14:56-64. doi: 10.1016/j.arr.2014.01.007. Epub 2014 Feb 5. Review.

PMID:
24509411
17.

Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: development, characterization and in vitro evaluation of their antitumoral efficacy.

Hernán Pérez de la Ossa D, Ligresti A, Gil-Alegre ME, Aberturas MR, Molpeceres J, Di Marzo V, Torres Suárez AI.

J Control Release. 2012 Aug 10;161(3):927-32. doi: 10.1016/j.jconrel.2012.05.003. Epub 2012 May 10.

PMID:
22580111
18.

Cannabidiol in humans-the quest for therapeutic targets.

Zhornitsky S, Potvin S.

Pharmaceuticals (Basel). 2012 May 21;5(5):529-52. doi: 10.3390/ph5050529.

19.

Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.

Marco EM, García-Gutiérrez MS, Bermúdez-Silva FJ, Moreira FA, Guimarães F, Manzanares J, Viveros MP.

Front Behav Neurosci. 2011 Oct 5;5:63. doi: 10.3389/fnbeh.2011.00063. eCollection 2011.

20.

Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.

Cannabis-In-Cachexia-Study-Group, Strasser F, Luftner D, Possinger K, Ernst G, Ruhstaller T, Meissner W, Ko YD, Schnelle M, Reif M, Cerny T.

J Clin Oncol. 2006 Jul 20;24(21):3394-400.

PMID:
16849753

Supplemental Content

Loading ...
Support Center